0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global CRISPR-based Gene Editing Tool Market Research Report 2026
Published Date: 2026-01-10
|
Report Code: QYRE-Auto-10P20391
Home | Market Reports | Science
Global CRISPR based Gene Editing Tool Market Research Report 2026
BUY CHAPTERS

Global CRISPR-based Gene Editing Tool Market Research Report 2026

Code: QYRE-Auto-10P20391
Report
2026-01-10
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

CRISPR-based Gene Editing Tool Market Size

The global CRISPR-based Gene Editing Tool market was valued at US$ 454 million in 2025 and is anticipated to reach US$ 641 million by 2032, at a CAGR of 5.1% from 2026 to 2032.

CRISPR-based Gene Editing Tool Market

CRISPR-based Gene Editing Tool Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on CRISPR-based Gene Editing Tool competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
CRISPR-based gene editing tool are molecular systems derived from bacterial immune mechanisms that allow scientists to precisely cut, modify, or regulate DNA within living cells. The core components include the Cas nuclease (such as Cas9 or Cas12) and a guide RNA that directs the nuclease to a specific DNA sequence, enabling targeted gene knockouts, insertions, corrections, or modulation of gene expression. These tools have reshaped biotechnology by offering high accuracy, programmability, and relative simplicity compared with earlier gene-editing methods. They are widely used in basic research, agriculture, drug discovery, and emerging therapeutic applications aimed at treating genetic diseases. Published list prices show wide dispersion: research-grade Cas proteins from ~€81 for 70 pmol Cas12a to ~€289 for 2000 pmol, ~$879–$1,022 for 500 µg Cas9.
CRISPR-based gene editing sits within a value chain that begins upstream with the development of core biological components—Cas enzymes (Cas9, Cas12, Cas13), guide RNA synthesis, delivery systems (viral vectors, lipid nanoparticles, RNP complexes), and specialized laboratory tools such as sequencing platforms, reagents, and cell-culture systems. These inputs feed into technology providers and research institutions that design, optimize, and validate CRISPR constructs, therapeutic pipelines, and agricultural or industrial applications. Downstream, CRISPR-enabled products and services flow into biotechnology and pharmaceutical companies developing gene therapies, diagnostics, and engineered cell lines; agricultural firms creating improved crops; and industrial or academic labs using CRISPR for basic research. Regulatory agencies, clinical trial service providers, and intellectual-property licensors form the final part of the chain. In short, CRISPR gene editing relies on an upstream supply of enzymes, guide RNAs, and delivery technologies, and serves downstream markets in therapeutics, diagnostics, agriculture, and scientific research.
The North American market for CRISPR-based Gene Editing Tool is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for CRISPR-based Gene Editing Tool is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of CRISPR-based Gene Editing Tool include Thermo Fisher Scientific, Merck KGaA, Integrated DNA Technologies (IDT), Takara Bio, New England Biolabs, GenScript, Aldevron, TriLink Biotechnologies, Synthego, KACTUS Bio, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global CRISPR-based Gene Editing Tool market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding CRISPR-based Gene Editing Tool. The CRISPR-based Gene Editing Tool market size, estimates, and forecasts are provided in terms of sales volume (pmol) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global CRISPR-based Gene Editing Tool market comprehensively. Regional market sizes by Type, by Application, by Grade, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist CRISPR-based Gene Editing Tool manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of CRISPR-based Gene Editing Tool Market Report

Report Metric Details
Report Name CRISPR-based Gene Editing Tool Market
Accounted market size in 2025 US$ 454 million
Forecasted market size in 2032 US$ 641 million
CAGR 5.1%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • CRISPR-Cas9
  • CRISPR-Cas12a (Cpf1)
  • Base Editors (CBE & ABE)
  • Others
Segment by Grade
  • Research Grade
  • GMP Grade
by Application
  • Basic Research
  • Biomedicine
  • Agriculture
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thermo Fisher Scientific, Merck KGaA, Integrated DNA Technologies (IDT), Takara Bio, New England Biolabs, GenScript, Aldevron, TriLink Biotechnologies, Synthego, KACTUS Bio, Shandong Shunfeng Biotechnology, Renman Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Grade, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for CRISPR-based Gene Editing Tool manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines CRISPR-based Gene Editing Tool sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is CRISPR-based Gene Editing Tool Market growing?

Ans: The CRISPR-based Gene Editing Tool Market witnessing a CAGR of 5.1% during the forecast period 2026-2032.

What is the CRISPR-based Gene Editing Tool Market size in 2032?

Ans: The CRISPR-based Gene Editing Tool Market size in 2032 will be US$ 641 million.

Who are the main players in the CRISPR-based Gene Editing Tool Market report?

Ans: The main players in the CRISPR-based Gene Editing Tool Market are Thermo Fisher Scientific, Merck KGaA, Integrated DNA Technologies (IDT), Takara Bio, New England Biolabs, GenScript, Aldevron, TriLink Biotechnologies, Synthego, KACTUS Bio, Shandong Shunfeng Biotechnology, Renman Biotechnology

What are the Application segmentation covered in the CRISPR-based Gene Editing Tool Market report?

Ans: The Applications covered in the CRISPR-based Gene Editing Tool Market report are Basic Research, Biomedicine, Agriculture, Others

What are the Type segmentation covered in the CRISPR-based Gene Editing Tool Market report?

Ans: The Types covered in the CRISPR-based Gene Editing Tool Market report are CRISPR-Cas9, CRISPR-Cas12a (Cpf1), Base Editors (CBE & ABE), Others

1 CRISPR-based Gene Editing Tool Market Overview
1.1 Product Definition
1.2 CRISPR-based Gene Editing Tool by Type
1.2.1 Global CRISPR-based Gene Editing Tool Market Value by Type: 2025 vs 2032
1.2.2 CRISPR-Cas9
1.2.3 CRISPR-Cas12a (Cpf1)
1.2.4 Base Editors (CBE & ABE)
1.2.5 Others
1.3 CRISPR-based Gene Editing Tool by Grade
1.3.1 Global CRISPR-based Gene Editing Tool Market Value by Grade: 2025 vs 2032
1.3.2 Research Grade
1.3.3 GMP Grade
1.4 CRISPR-based Gene Editing Tool by Application
1.4.1 Global CRISPR-based Gene Editing Tool Market Value by Application: 2025 vs 2032
1.4.2 Basic Research
1.4.3 Biomedicine
1.4.4 Agriculture
1.4.5 Others
1.5 Global CRISPR-based Gene Editing Tool Market Size Estimates and Forecasts
1.5.1 Global CRISPR-based Gene Editing Tool Revenue 2021–2032
1.5.2 Global CRISPR-based Gene Editing Tool Sales 2021–2032
1.5.3 Global CRISPR-based Gene Editing Tool Market Average Price (2021–2032)
1.6 Assumptions and Limitations
2 CRISPR-based Gene Editing Tool Market Competition by Manufacturers
2.1 Global CRISPR-based Gene Editing Tool Sales Market Share by Manufacturers (2021–2026)
2.2 Global CRISPR-based Gene Editing Tool Revenue Market Share by Manufacturers (2021–2026)
2.3 Global CRISPR-based Gene Editing Tool Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of CRISPR-based Gene Editing Tool, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of CRISPR-based Gene Editing Tool, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of CRISPR-based Gene Editing Tool, Product Types and Applications
2.7 Global Key Manufacturers of CRISPR-based Gene Editing Tool, Date of Entry into the Industry
2.8 Global CRISPR-based Gene Editing Tool Market Competitive Situation and Trends
2.8.1 Global CRISPR-based Gene Editing Tool Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global CRISPR-based Gene Editing Tool Players Market Share by Revenue
2.8.3 Global CRISPR-based Gene Editing Tool Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global CRISPR-based Gene Editing Tool Market Scenario by Region
3.1 Global CRISPR-based Gene Editing Tool Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global CRISPR-based Gene Editing Tool Sales by Region: 2021–2032
3.2.1 Global CRISPR-based Gene Editing Tool Sales by Region: 2021–2026
3.2.2 Global CRISPR-based Gene Editing Tool Sales by Region: 2027–2032
3.3 Global CRISPR-based Gene Editing Tool Revenue by Region: 2021–2032
3.3.1 Global CRISPR-based Gene Editing Tool Revenue by Region: 2021–2026
3.3.2 Global CRISPR-based Gene Editing Tool Revenue by Region: 2027–2032
3.4 North America CRISPR-based Gene Editing Tool Market Facts & Figures by Country
3.4.1 North America CRISPR-based Gene Editing Tool Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America CRISPR-based Gene Editing Tool Sales by Country (2021–2032)
3.4.3 North America CRISPR-based Gene Editing Tool Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe CRISPR-based Gene Editing Tool Market Facts & Figures by Country
3.5.1 Europe CRISPR-based Gene Editing Tool Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe CRISPR-based Gene Editing Tool Sales by Country (2021–2032)
3.5.3 Europe CRISPR-based Gene Editing Tool Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CRISPR-based Gene Editing Tool Market Facts & Figures by Region
3.6.1 Asia Pacific CRISPR-based Gene Editing Tool Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific CRISPR-based Gene Editing Tool Sales by Region (2021–2032)
3.6.3 Asia Pacific CRISPR-based Gene Editing Tool Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America CRISPR-based Gene Editing Tool Market Facts & Figures by Country
3.7.1 Latin America CRISPR-based Gene Editing Tool Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America CRISPR-based Gene Editing Tool Sales by Country (2021–2032)
3.7.3 Latin America CRISPR-based Gene Editing Tool Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa CRISPR-based Gene Editing Tool Market Facts & Figures by Country
3.8.1 Middle East and Africa CRISPR-based Gene Editing Tool Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa CRISPR-based Gene Editing Tool Sales by Country (2021–2032)
3.8.3 Middle East and Africa CRISPR-based Gene Editing Tool Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CRISPR-based Gene Editing Tool Sales by Type (2021–2032)
4.1.1 Global CRISPR-based Gene Editing Tool Sales by Type (2021–2026)
4.1.2 Global CRISPR-based Gene Editing Tool Sales by Type (2027–2032)
4.1.3 Global CRISPR-based Gene Editing Tool Sales Market Share by Type (2021–2032)
4.2 Global CRISPR-based Gene Editing Tool Revenue by Type (2021–2032)
4.2.1 Global CRISPR-based Gene Editing Tool Revenue by Type (2021–2026)
4.2.2 Global CRISPR-based Gene Editing Tool Revenue by Type (2027–2032)
4.2.3 Global CRISPR-based Gene Editing Tool Revenue Market Share by Type (2021–2032)
4.3 Global CRISPR-based Gene Editing Tool Price by Type (2021–2032)
5 Segment by Application
5.1 Global CRISPR-based Gene Editing Tool Sales by Application (2021–2032)
5.1.1 Global CRISPR-based Gene Editing Tool Sales by Application (2021–2026)
5.1.2 Global CRISPR-based Gene Editing Tool Sales by Application (2027–2032)
5.1.3 Global CRISPR-based Gene Editing Tool Sales Market Share by Application (2021–2032)
5.2 Global CRISPR-based Gene Editing Tool Revenue by Application (2021–2032)
5.2.1 Global CRISPR-based Gene Editing Tool Revenue by Application (2021–2026)
5.2.2 Global CRISPR-based Gene Editing Tool Revenue by Application (2027–2032)
5.2.3 Global CRISPR-based Gene Editing Tool Revenue Market Share by Application (2021–2032)
5.3 Global CRISPR-based Gene Editing Tool Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Company Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific CRISPR-based Gene Editing Tool Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Thermo Fisher Scientific CRISPR-based Gene Editing Tool Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Merck KGaA
6.2.1 Merck KGaA Company Information
6.2.2 Merck KGaA Description and Business Overview
6.2.3 Merck KGaA CRISPR-based Gene Editing Tool Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck KGaA CRISPR-based Gene Editing Tool Product Portfolio
6.2.5 Merck KGaA Recent Developments/Updates
6.3 Integrated DNA Technologies (IDT)
6.3.1 Integrated DNA Technologies (IDT) Company Information
6.3.2 Integrated DNA Technologies (IDT) Description and Business Overview
6.3.3 Integrated DNA Technologies (IDT) CRISPR-based Gene Editing Tool Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Integrated DNA Technologies (IDT) CRISPR-based Gene Editing Tool Product Portfolio
6.3.5 Integrated DNA Technologies (IDT) Recent Developments/Updates
6.4 Takara Bio
6.4.1 Takara Bio Company Information
6.4.2 Takara Bio Description and Business Overview
6.4.3 Takara Bio CRISPR-based Gene Editing Tool Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Takara Bio CRISPR-based Gene Editing Tool Product Portfolio
6.4.5 Takara Bio Recent Developments/Updates
6.5 New England Biolabs
6.5.1 New England Biolabs Company Information
6.5.2 New England Biolabs Description and Business Overview
6.5.3 New England Biolabs CRISPR-based Gene Editing Tool Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 New England Biolabs CRISPR-based Gene Editing Tool Product Portfolio
6.5.5 New England Biolabs Recent Developments/Updates
6.6 GenScript
6.6.1 GenScript Company Information
6.6.2 GenScript Description and Business Overview
6.6.3 GenScript CRISPR-based Gene Editing Tool Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 GenScript CRISPR-based Gene Editing Tool Product Portfolio
6.6.5 GenScript Recent Developments/Updates
6.7 Aldevron
6.7.1 Aldevron Company Information
6.7.2 Aldevron Description and Business Overview
6.7.3 Aldevron CRISPR-based Gene Editing Tool Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Aldevron CRISPR-based Gene Editing Tool Product Portfolio
6.7.5 Aldevron Recent Developments/Updates
6.8 TriLink Biotechnologies
6.8.1 TriLink Biotechnologies Company Information
6.8.2 TriLink Biotechnologies Description and Business Overview
6.8.3 TriLink Biotechnologies CRISPR-based Gene Editing Tool Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 TriLink Biotechnologies CRISPR-based Gene Editing Tool Product Portfolio
6.8.5 TriLink Biotechnologies Recent Developments/Updates
6.9 Synthego
6.9.1 Synthego Company Information
6.9.2 Synthego Description and Business Overview
6.9.3 Synthego CRISPR-based Gene Editing Tool Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Synthego CRISPR-based Gene Editing Tool Product Portfolio
6.9.5 Synthego Recent Developments/Updates
6.10 KACTUS Bio
6.10.1 KACTUS Bio Company Information
6.10.2 KACTUS Bio Description and Business Overview
6.10.3 KACTUS Bio CRISPR-based Gene Editing Tool Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 KACTUS Bio CRISPR-based Gene Editing Tool Product Portfolio
6.10.5 KACTUS Bio Recent Developments/Updates
6.11 Shandong Shunfeng Biotechnology
6.11.1 Shandong Shunfeng Biotechnology Company Information
6.11.2 Shandong Shunfeng Biotechnology Description and Business Overview
6.11.3 Shandong Shunfeng Biotechnology CRISPR-based Gene Editing Tool Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Shandong Shunfeng Biotechnology CRISPR-based Gene Editing Tool Product Portfolio
6.11.5 Shandong Shunfeng Biotechnology Recent Developments/Updates
6.12 Renman Biotechnology
6.12.1 Renman Biotechnology Company Information
6.12.2 Renman Biotechnology Description and Business Overview
6.12.3 Renman Biotechnology CRISPR-based Gene Editing Tool Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Renman Biotechnology CRISPR-based Gene Editing Tool Product Portfolio
6.12.5 Renman Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CRISPR-based Gene Editing Tool Industry Chain Analysis
7.2 CRISPR-based Gene Editing Tool Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CRISPR-based Gene Editing Tool Production Mode & Process Analysis
7.4 CRISPR-based Gene Editing Tool Sales and Marketing
7.4.1 CRISPR-based Gene Editing Tool Sales Channels
7.4.2 CRISPR-based Gene Editing Tool Distributors
7.5 CRISPR-based Gene Editing Tool Customer Analysis
8 CRISPR-based Gene Editing Tool Market Dynamics
8.1 CRISPR-based Gene Editing Tool Industry Trends
8.2 CRISPR-based Gene Editing Tool Market Drivers
8.3 CRISPR-based Gene Editing Tool Market Challenges
8.4 CRISPR-based Gene Editing Tool Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global CRISPR-based Gene Editing Tool Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global CRISPR-based Gene Editing Tool Market Value by Grade (US$ Million), 2025 vs 2032
 Table 3. Global CRISPR-based Gene Editing Tool Market Value by Application (US$ Million), 2025 vs 2032
 Table 4. Global CRISPR-based Gene Editing Tool Market Competitive Situation by Manufacturers in 2025
 Table 5. Global CRISPR-based Gene Editing Tool Sales (pmol) of Key Manufacturers (2021–2026)
 Table 6. Global CRISPR-based Gene Editing Tool Sales Market Share by Manufacturers (2021–2026)
 Table 7. Global CRISPR-based Gene Editing Tool Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 8. Global CRISPR-based Gene Editing Tool Revenue Share by Manufacturers (2021–2026)
 Table 9. Global Market CRISPR-based Gene Editing Tool Average Price (US$/pmol) of Key Manufacturers (2021–2026)
 Table 10. Global Key Players of CRISPR-based Gene Editing Tool, Industry Ranking, 2023 vs 2024 vs 2025
 Table 11. Global Key Manufacturers of CRISPR-based Gene Editing Tool, Manufacturing Sites and Headquarters
 Table 12. Global Key Manufacturers of CRISPR-based Gene Editing Tool, Product Types and Applications
 Table 13. Global Key Manufacturers of CRISPR-based Gene Editing Tool, Date of Entry into the Industry
 Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Global CRISPR-based Gene Editing Tool Companies by Tier (Tier 1, Tier 2, Tier 3), based on CRISPR-based Gene Editing Tool Revenue, 2025
 Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 17. Global CRISPR-based Gene Editing Tool Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 18. Global CRISPR-based Gene Editing Tool Sales by Region (pmol), 2021–2026
 Table 19. Global CRISPR-based Gene Editing Tool Sales Market Share by Region (2021–2026)
 Table 20. Global CRISPR-based Gene Editing Tool Sales by Region (pmol), 2027–2032
 Table 21. Global CRISPR-based Gene Editing Tool Sales Market Share by Region (2027–2032)
 Table 22. Global CRISPR-based Gene Editing Tool Revenue by Region (US$ Million), 2021–2026
 Table 23. Global CRISPR-based Gene Editing Tool Revenue Market Share by Region (2021–2026)
 Table 24. Global CRISPR-based Gene Editing Tool Revenue by Region (US$ Million), 2027–2032
 Table 25. Global CRISPR-based Gene Editing Tool Revenue Market Share by Region (2027–2032)
 Table 26. North America CRISPR-based Gene Editing Tool Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 27. North America CRISPR-based Gene Editing Tool Sales by Country (pmol), 2021–2026
 Table 28. North America CRISPR-based Gene Editing Tool Sales by Country (pmol), 2027–2032
 Table 29. North America CRISPR-based Gene Editing Tool Revenue by Country (US$ Million), 2021–2026
 Table 30. North America CRISPR-based Gene Editing Tool Revenue by Country (US$ Million), 2027–2032
 Table 31. Europe CRISPR-based Gene Editing Tool Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 32. Europe CRISPR-based Gene Editing Tool Sales by Country (pmol), 2021–2026
 Table 33. Europe CRISPR-based Gene Editing Tool Sales by Country (pmol), 2027–2032
 Table 34. Europe CRISPR-based Gene Editing Tool Revenue by Country (US$ Million), 2021–2026
 Table 35. Europe CRISPR-based Gene Editing Tool Revenue by Country (US$ Million), 2027–2032
 Table 36. Asia Pacific CRISPR-based Gene Editing Tool Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 37. Asia Pacific CRISPR-based Gene Editing Tool Sales by Region (pmol), 2021–2026
 Table 38. Asia Pacific CRISPR-based Gene Editing Tool Sales by Region (pmol), 2027–2032
 Table 39. Asia Pacific CRISPR-based Gene Editing Tool Revenue by Region (US$ Million), 2021–2026
 Table 40. Asia Pacific CRISPR-based Gene Editing Tool Revenue by Region (US$ Million), 2027–2032
 Table 41. Latin America CRISPR-based Gene Editing Tool Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 42. Latin America CRISPR-based Gene Editing Tool Sales by Country (pmol), 2021–2026
 Table 43. Latin America CRISPR-based Gene Editing Tool Sales by Country (pmol), 2027–2032
 Table 44. Latin America CRISPR-based Gene Editing Tool Revenue by Country (US$ Million), 2021–2026
 Table 45. Latin America CRISPR-based Gene Editing Tool Revenue by Country (US$ Million), 2027–2032
 Table 46. Middle East and Africa CRISPR-based Gene Editing Tool Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 47. Middle East and Africa CRISPR-based Gene Editing Tool Sales by Country (pmol), 2021–2026
 Table 48. Middle East and Africa CRISPR-based Gene Editing Tool Sales by Country (pmol), 2027–2032
 Table 49. Middle East and Africa CRISPR-based Gene Editing Tool Revenue by Country (US$ Million), 2021–2026
 Table 50. Middle East and Africa CRISPR-based Gene Editing Tool Revenue by Country (US$ Million), 2027–2032
 Table 51. Global CRISPR-based Gene Editing Tool Sales (pmol) by Type (2021–2026)
 Table 52. Global CRISPR-based Gene Editing Tool Sales (pmol) by Type (2027–2032)
 Table 53. Global CRISPR-based Gene Editing Tool Sales Market Share by Type (2021–2026)
 Table 54. Global CRISPR-based Gene Editing Tool Sales Market Share by Type (2027–2032)
 Table 55. Global CRISPR-based Gene Editing Tool Revenue (US$ Million) by Type (2021–2026)
 Table 56. Global CRISPR-based Gene Editing Tool Revenue (US$ Million) by Type (2027–2032)
 Table 57. Global CRISPR-based Gene Editing Tool Revenue Market Share by Type (2021–2026)
 Table 58. Global CRISPR-based Gene Editing Tool Revenue Market Share by Type (2027–2032)
 Table 59. Global CRISPR-based Gene Editing Tool Price (US$/pmol) by Type (2021–2026)
 Table 60. Global CRISPR-based Gene Editing Tool Price (US$/pmol) by Type (2027–2032)
 Table 61. Global CRISPR-based Gene Editing Tool Sales (pmol) by Application (2021–2026)
 Table 62. Global CRISPR-based Gene Editing Tool Sales (pmol) by Application (2027–2032)
 Table 63. Global CRISPR-based Gene Editing Tool Sales Market Share by Application (2021–2026)
 Table 64. Global CRISPR-based Gene Editing Tool Sales Market Share by Application (2027–2032)
 Table 65. Global CRISPR-based Gene Editing Tool Revenue (US$ Million) by Application (2021–2026)
 Table 66. Global CRISPR-based Gene Editing Tool Revenue (US$ Million) by Application (2027–2032)
 Table 67. Global CRISPR-based Gene Editing Tool Revenue Market Share by Application (2021–2026)
 Table 68. Global CRISPR-based Gene Editing Tool Revenue Market Share by Application (2027–2032)
 Table 69. Global CRISPR-based Gene Editing Tool Price (US$/pmol) by Application (2021–2026)
 Table 70. Global CRISPR-based Gene Editing Tool Price (US$/pmol) by Application (2027–2032)
 Table 71. Thermo Fisher Scientific Company Information
 Table 72. Thermo Fisher Scientific Description and Business Overview
 Table 73. Thermo Fisher Scientific CRISPR-based Gene Editing Tool Sales (pmol), Revenue (US$ Million), Price (US$/pmol), and Gross Margin (2021–2026)
 Table 74. Thermo Fisher Scientific CRISPR-based Gene Editing Tool Product
 Table 75. Thermo Fisher Scientific Recent Developments/Updates
 Table 76. Merck KGaA Company Information
 Table 77. Merck KGaA Description and Business Overview
 Table 78. Merck KGaA CRISPR-based Gene Editing Tool Sales (pmol), Revenue (US$ Million), Price (US$/pmol), and Gross Margin (2021–2026)
 Table 79. Merck KGaA CRISPR-based Gene Editing Tool Product
 Table 80. Merck KGaA Recent Developments/Updates
 Table 81. Integrated DNA Technologies (IDT) Company Information
 Table 82. Integrated DNA Technologies (IDT) Description and Business Overview
 Table 83. Integrated DNA Technologies (IDT) CRISPR-based Gene Editing Tool Sales (pmol), Revenue (US$ Million), Price (US$/pmol), and Gross Margin (2021–2026)
 Table 84. Integrated DNA Technologies (IDT) CRISPR-based Gene Editing Tool Product
 Table 85. Integrated DNA Technologies (IDT) Recent Developments/Updates
 Table 86. Takara Bio Company Information
 Table 87. Takara Bio Description and Business Overview
 Table 88. Takara Bio CRISPR-based Gene Editing Tool Sales (pmol), Revenue (US$ Million), Price (US$/pmol), and Gross Margin (2021–2026)
 Table 89. Takara Bio CRISPR-based Gene Editing Tool Product
 Table 90. Takara Bio Recent Developments/Updates
 Table 91. New England Biolabs Company Information
 Table 92. New England Biolabs Description and Business Overview
 Table 93. New England Biolabs CRISPR-based Gene Editing Tool Sales (pmol), Revenue (US$ Million), Price (US$/pmol), and Gross Margin (2021–2026)
 Table 94. New England Biolabs CRISPR-based Gene Editing Tool Product
 Table 95. New England Biolabs Recent Developments/Updates
 Table 96. GenScript Company Information
 Table 97. GenScript Description and Business Overview
 Table 98. GenScript CRISPR-based Gene Editing Tool Sales (pmol), Revenue (US$ Million), Price (US$/pmol), and Gross Margin (2021–2026)
 Table 99. GenScript CRISPR-based Gene Editing Tool Product
 Table 100. GenScript Recent Developments/Updates
 Table 101. Aldevron Company Information
 Table 102. Aldevron Description and Business Overview
 Table 103. Aldevron CRISPR-based Gene Editing Tool Sales (pmol), Revenue (US$ Million), Price (US$/pmol), and Gross Margin (2021–2026)
 Table 104. Aldevron CRISPR-based Gene Editing Tool Product
 Table 105. Aldevron Recent Developments/Updates
 Table 106. TriLink Biotechnologies Company Information
 Table 107. TriLink Biotechnologies Description and Business Overview
 Table 108. TriLink Biotechnologies CRISPR-based Gene Editing Tool Sales (pmol), Revenue (US$ Million), Price (US$/pmol), and Gross Margin (2021–2026)
 Table 109. TriLink Biotechnologies CRISPR-based Gene Editing Tool Product
 Table 110. TriLink Biotechnologies Recent Developments/Updates
 Table 111. Synthego Company Information
 Table 112. Synthego Description and Business Overview
 Table 113. Synthego CRISPR-based Gene Editing Tool Sales (pmol), Revenue (US$ Million), Price (US$/pmol), and Gross Margin (2021–2026)
 Table 114. Synthego CRISPR-based Gene Editing Tool Product
 Table 115. Synthego Recent Developments/Updates
 Table 116. KACTUS Bio Company Information
 Table 117. KACTUS Bio Description and Business Overview
 Table 118. KACTUS Bio CRISPR-based Gene Editing Tool Sales (pmol), Revenue (US$ Million), Price (US$/pmol), and Gross Margin (2021–2026)
 Table 119. KACTUS Bio CRISPR-based Gene Editing Tool Product
 Table 120. KACTUS Bio Recent Developments/Updates
 Table 121. Shandong Shunfeng Biotechnology Company Information
 Table 122. Shandong Shunfeng Biotechnology Description and Business Overview
 Table 123. Shandong Shunfeng Biotechnology CRISPR-based Gene Editing Tool Sales (pmol), Revenue (US$ Million), Price (US$/pmol), and Gross Margin (2021–2026)
 Table 124. Shandong Shunfeng Biotechnology CRISPR-based Gene Editing Tool Product
 Table 125. Shandong Shunfeng Biotechnology Recent Developments/Updates
 Table 126. Renman Biotechnology Company Information
 Table 127. Renman Biotechnology Description and Business Overview
 Table 128. Renman Biotechnology CRISPR-based Gene Editing Tool Sales (pmol), Revenue (US$ Million), Price (US$/pmol), and Gross Margin (2021–2026)
 Table 129. Renman Biotechnology CRISPR-based Gene Editing Tool Product
 Table 130. Renman Biotechnology Recent Developments/Updates
 Table 131. Key Raw Materials Lists
 Table 132. Raw Materials Key Suppliers Lists
 Table 133. CRISPR-based Gene Editing Tool Distributors List
 Table 134. CRISPR-based Gene Editing Tool Customers List
 Table 135. CRISPR-based Gene Editing Tool Market Trends
 Table 136. CRISPR-based Gene Editing Tool Market Drivers
 Table 137. CRISPR-based Gene Editing Tool Market Challenges
 Table 138. CRISPR-based Gene Editing Tool Market Restraints
 Table 139. Research Programs/Design for This Report
 Table 140. Key Data Information from Secondary Sources
 Table 141. Key Data Information from Primary Sources
 Table 142. Authors List of This Report


List of Figures
 Figure 1. Product Picture of CRISPR-based Gene Editing Tool
 Figure 2. Global CRISPR-based Gene Editing Tool Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global CRISPR-based Gene Editing Tool Market Share by Type: 2025 & 2032
 Figure 4. CRISPR-Cas9 Product Picture
 Figure 5. CRISPR-Cas12a (Cpf1) Product Picture
 Figure 6. Base Editors (CBE & ABE) Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global CRISPR-based Gene Editing Tool Market Value by Grade (US$ Million), 2021–2032
 Figure 9. Global CRISPR-based Gene Editing Tool Market Share by Grade: 2025 vs 2032
 Figure 10. Research Grade Product Picture
 Figure 11. GMP Grade Product Picture
 Figure 12. Global CRISPR-based Gene Editing Tool Market Value by Application (US$ Million), 2021–2032
 Figure 13. Global CRISPR-based Gene Editing Tool Market Share by Application: 2025 & 2032
 Figure 14. Basic Research
 Figure 15. Biomedicine
 Figure 16. Agriculture
 Figure 17. Others
 Figure 18. Global CRISPR-based Gene Editing Tool Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 19. Global CRISPR-based Gene Editing Tool Market Size (US$ Million), 2021–2032
 Figure 20. Global CRISPR-based Gene Editing Tool Sales (pmol), 2021–2032
 Figure 21. Global CRISPR-based Gene Editing Tool Average Price (US$/pmol), 2021–2032
 Figure 22. CRISPR-based Gene Editing Tool Report Years Considered
 Figure 23. CRISPR-based Gene Editing Tool Sales Share by Manufacturers in 2025
 Figure 24. Global CRISPR-based Gene Editing Tool Revenue Share by Manufacturers in 2025
 Figure 25. Top 5 and Top 10 Global CRISPR-based Gene Editing Tool Players: Market Share by Revenue in CRISPR-based Gene Editing Tool in 2025
 Figure 26. CRISPR-based Gene Editing Tool Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 27. Global CRISPR-based Gene Editing Tool Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 28. North America CRISPR-based Gene Editing Tool Sales Market Share by Country (2021–2032)
 Figure 29. North America CRISPR-based Gene Editing Tool Revenue Market Share by Country (2021–2032)
 Figure 30. United States CRISPR-based Gene Editing Tool Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Canada CRISPR-based Gene Editing Tool Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Europe CRISPR-based Gene Editing Tool Sales Market Share by Country (2021–2032)
 Figure 33. Europe CRISPR-based Gene Editing Tool Revenue Market Share by Country (2021–2032)
 Figure 34. Germany CRISPR-based Gene Editing Tool Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. France CRISPR-based Gene Editing Tool Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. U.K. CRISPR-based Gene Editing Tool Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Italy CRISPR-based Gene Editing Tool Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Russia CRISPR-based Gene Editing Tool Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Asia Pacific CRISPR-based Gene Editing Tool Sales Market Share by Region (2021–2032)
 Figure 40. Asia Pacific CRISPR-based Gene Editing Tool Revenue Market Share by Region (2021–2032)
 Figure 41. China CRISPR-based Gene Editing Tool Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Japan CRISPR-based Gene Editing Tool Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. South Korea CRISPR-based Gene Editing Tool Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. India CRISPR-based Gene Editing Tool Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Australia CRISPR-based Gene Editing Tool Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. China Taiwan CRISPR-based Gene Editing Tool Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Southeast Asia CRISPR-based Gene Editing Tool Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Latin America CRISPR-based Gene Editing Tool Sales Market Share by Country (2021–2032)
 Figure 49. Latin America CRISPR-based Gene Editing Tool Revenue Market Share by Country (2021–2032)
 Figure 50. Mexico CRISPR-based Gene Editing Tool Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Brazil CRISPR-based Gene Editing Tool Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Argentina CRISPR-based Gene Editing Tool Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Colombia CRISPR-based Gene Editing Tool Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Middle East and Africa CRISPR-based Gene Editing Tool Sales Market Share by Country (2021–2032)
 Figure 55. Middle East and Africa CRISPR-based Gene Editing Tool Revenue Market Share by Country (2021–2032)
 Figure 56. Turkey CRISPR-based Gene Editing Tool Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. Saudi Arabia CRISPR-based Gene Editing Tool Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. UAE CRISPR-based Gene Editing Tool Revenue Growth Rate (US$ Million), 2021–2032
 Figure 59. Global Sales Market Share of CRISPR-based Gene Editing Tool by Type (2021–2032)
 Figure 60. Global Revenue Market Share of CRISPR-based Gene Editing Tool by Type (2021–2032)
 Figure 61. Global CRISPR-based Gene Editing Tool Price (US$/pmol) by Type (2021–2032)
 Figure 62. Global Sales Market Share of CRISPR-based Gene Editing Tool by Application (2021–2032)
 Figure 63. Global Revenue Market Share of CRISPR-based Gene Editing Tool by Application (2021–2032)
 Figure 64. Global CRISPR-based Gene Editing Tool Price (US$/pmol) by Application (2021–2032)
 Figure 65. CRISPR-based Gene Editing Tool Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS